Four teams supported by SU2C focus on increasing diversity in early phase cancer clinical trials

Stand Up To Cancer today announced four teams focused on increasing diversity in early phase cancer clinical trials.

Related Keywords

Foxchase Cancer Center ,Pennsylvania ,United States ,University Of Chicago ,Illinois ,Dallas ,Texas ,Chicago ,Philadelphia ,Americans ,Chika Nwachukwu ,David Gerber ,Walter Stadler ,Linda Fleisher ,Briseis Aschebrook Kilfoy ,Jeffrey Infante ,Emily Henderson ,Martin Edelman ,Anthony El Khoueiry ,Chanita Hughes Halbert ,Los Angeles ,Diversity In Early Development Clinical Trials Program ,Cancer Research Industry ,C Health Equity Initiative ,Drug Administration ,Oncology Early Clinical Development ,Janssen Research Development ,Janssen Pharmaceutical Companies Of Johnson ,Cancer Research ,National Cancer ,Underserved Community ,Translational Research ,Janssen Pharmaceutical Companies ,Early Development Clinical Trials Program ,Health Equity Initiative ,Janssen Research ,Early Development Clinical Trials Research Teams ,Diversifying Access ,Clinical Trials ,North Philadelphia ,Research Industry Focus ,Enrollment Barriers ,Early Phase Trials ,Diverse Population ,Los Angeles County ,Early Phase Clinical Trials ,Urban Underserved Community ,Enhance Access ,Early Phase Cancer Clinical Trials ,Medical Center ,Comprehensive Cancer Center ,National Cancer Institute Designated ,Cancer ,Clinical Trial ,Electronic Health Record ,Hospital ,Ncology ,Research ,